U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
--------------------
SEC FILE NUMBER
072
--------------------
CUSIP NUMBER
987048105
--------------------
Check One):
[ ] Form 10-K and Form 10-KSB [ ] Form 11-K [ ] Form 20-F
[ X ] Form 10-Q and Form 10-QSB [ ] Form N-SAR
For Period Ended: November 30, 2001
-----------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ............................
-------------------------------------------------------------------------------
Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
-------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:........................
...............................................................................
-------------------------------------------------------------------------------
Part I. Registrant Information
-------------------------------------------------------------------------------
Full Name of Registrant:
Former Name if Applicable:
York Research Corporation
-------------------------------------------------------------------------------
Address of principal executive office (Street and number)
280 Park Avenue, Suite 2700 West
----------------------------------------------------------------------
City, State and Zip Code New York, New York 10017
-------------------------------------------------------------------------------
Part II. Rule 12b-25 (b) and (c)
-------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed (Check box if appropriate.)
[ ] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K or Form 10-KSB, 20-F, 11-K or Form N-SAR, or portion thereof
will be filed on or before the 15th calendar day following the
prescribed due date; or the subject quarterly report or transition
report on Form 10-Q or Form 10-QSB, or portion thereof will be filed on
or before the fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
-------------------------------------------------------------------------------
Part III. Narrative
-------------------------------------------------------------------------------
State below in reasonable detail the reasons why Form 10-K and Form
10-KSB, 11-K, 20-F, 10-Q and Form 10-QSB, N-SAR, or the transition report or
portion thereof could not be filed within the prescribed period. (Attach extra
sheets if needed.)
The Company is waiting for additional information needed to complete
the Form 10-Q.
-------------------------------------------------------------------------------
Part IV. Other Information
-------------------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to this
notification
Michael Trachtenberg (212) 557-6200
-------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[X] Yes [ ] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
York Research Corporation
--------------------------------------------
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date January 14, 2002 /S/Michael Trachtenberg
--------------------- -----------------------
Michael Trachtenberg, EVP and
Chief Accounting and Officer
ATTENTION
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (see 18 U.S.C. 1001).
YORK RESEARCH CORPORATION
FORM 12b-25
PART IV (3)
(Unaudited) (Unaudited)
For the Nine Months For the Three Months
Ended November 30, Ended November 30,
-------------------------------- -------------------------------
2001 2000 2001 2000
--------------- -------------- -------------- --------------
Revenues $ 25,447,438 $ 27,190,103 $ 7,532,488 $ 10,119,770
Net income (loss) $ 280,939 $ 2,141,640 $ (1,336,202) $ 750,615
Earnings (loss) per share - Basic $ 0.02 $ 0.14 $ (0.08) $ 0.05
Weighted average number of common shares used in
computing basic earnings (loss) per share 16,073,052 15,139,011 16,089,008 15,153,137
Earnings (loss) per share - Diluted $ 0.02 $ 0.14 $ (0.08) $ 0.05
Weighted average number of common shares and
common shares equivalents used in computing diluted
earnings (loss) per share 17,453,638 15,139,011 16,089,008 15,153,137